Rubius Therapeutics, Inc.

Bank of New York Mellon Corp

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/14/2023

Shares

20,990

Value ($000)

4

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/14/2023	4	0.0%	20,990	12/31/2022
2022 Q3	11/14/2022	9	0.0%	20,990	9/30/2022
2022 Q2	8/15/2022	18	0.0%	20,990	6/30/2022
2022 Q1	5/11/2022	811	0.0%	147,257	3/31/2022
2021 Q4	2/11/2022	1,435	0.0%	148,260	12/31/2021
2021 Q3	11/18/2021	3,408	0.0%	190,609	9/30/2021
2021 Q2	8/11/2021	5,165	0.0%	211,601	6/30/2021
2021 Q1	5/13/2021	5,112	0.0%	192,893	3/31/2021
2020 Q4	2/9/2021	1,198	0.0%	157,810	12/31/2020
2020 Q3	11/12/2020	755	0.0%	150,876	9/30/2020
2020 Q2	8/12/2020	904	0.0%	151,224	6/30/2020
2020 Q1	5/6/2020	583	0.0%	131,171	3/31/2020
2019 Q4	2/14/2020	1,328	0.0%	139,785	12/31/2019